You are here

Mutations

Pfizer CEO says omicron vaccine will be ready in March

fizer CEO Albert Bourla said a vaccine that targets the omicron variant of Covid will be ready in March, and the company’s already begun manufacturing the doses.

“This vaccine will be ready in March,” Bourla told CNBC’s Squawk Box. “We (are) already starting manufacturing some of these quantities at risk.”

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

A fourth of U.S. hospitals are reporting a critical staff shortage as Omicron drives a rise in Covid-19 cases

(CNN) About 24% of US hospitals are reporting a "critical staffing shortage," according to data from the US Department of Health and Human Services, as public health experts warn the Covid-19 surge fueled by the Omicron variant threatens the nation's health care system.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Cyprus researcher reports a Covid variant that combines omicron and delta

 

Cyprus reportedly discovers a Covid variant that combines omicron and delta

A researcher in Cyprus has discovered a strain of the coronavirus that combines the delta and omicron variant, Bloomberg News reported on Saturday.

Leondios Kostrikis, professor of biological sciences at the University of Cyprus, called the strain “deltacron,” because of its omicron-like genetic signatures within the delta genomes, Bloomberg said.

So far, Kostrikis and his team have found 25 cases of the virus, according to the report. It’s still too early to tell whether there are more cases of the strain or what impacts it could have.

“We will see in the future if this strain is more pathological or more contagious or if it will prevail” against the two dominant strains, delta and omicron, Kostrikis said in an interview with Sigma TV Friday. He believes omicron will also overtake deltacron, he added.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

American hospitals: variations in the COVID wave

The number of Americans hospitalized with covid-19 reached more than 126,000 this week — the highest level in a year. But this wave of the pandemic looks different from what came before, with dueling variants on the move.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

A fourth Moderna covid shot may eventuallty be needed as efficacy of boosters likely to decline over time

Moderna CEO warns people may need fourth Covid shot as efficacy of boosters likely to decline over time

 

Moderna CEO Stephane Bancel on Thursday said the efficacy of boosters against Covid-19 will likely decline over time, and people may need a fourth shot in the fall to increase their protection.

Bancel said people who received their boosters last fall will likely have enough protection to get them through the winter, when new infections surge as people gather indoors to escape the cold.

However, Bancel said the efficacy of boosters will probably decline over the course of several months, similar to what happened with the first two doses. The Moderna chief was interviewed by Goldman Sachs during the investment bank’s health-care CEO conference.

“I will be surprised when we get that data in the coming weeks that it’s holding nicely over time — I would expect that it’s not going to hold great,” Bancel said, referring to the strength of the booster shots.   ...

 

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Mutations
howdy folks
Page loaded in 0.641 seconds.